FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News

Study investigates how having a pet in early childhood can influence emotional development

A research team from the INMA Project (Childhood and Environment) has analyzed how pet ownership during early childhood may be related to emotional and behavioral well-being in children. The results suggest that both the ...

Screens that do good: How digital tools can help kids and teens stay healthy

Mobile phones and endless screen time are the bane of parents the world over. But while technology is often blamed for poor health in children and teenagers, new University of South Australia research suggests that the same ...

SNAP benefit disruptions causing more kids to go without enough healthy food and harming child development

About 4 in 10 of the more than 42 million Americans who get Supplemental Nutrition Assistance Program benefits are children under 18. This food aid helps their families buy groceries and boosts their health in many ways—both ...

Violence is a normal part of life for many young children: Study traces the mental health impacts

Children in many countries are growing up surrounded by violence. It may happen at home, in their neighborhoods, or both. Some children are directly harmed, while others witness violence between caregivers or in their communities. ...

Learning to see after being born blind: Brain imaging study highlights infant adaptability

Some babies are born with early blindness due to dense bilateral congenital cataracts, requiring surgery to restore their sight. This period of several months without vision can leave a lasting mark on how the brain processes ...

Online parent help program leads to less-anxious, happier children

Providing parenting help through schools led to a significant reduction in anxiety and behavioral problems among children, according to the results of a national study.

Todays Updates

PDS Ranibizumab Retains Visual Acuity Gains in nAMD, with John Kitchens, MD John W. Kitchens, MD

The ongoing Archway-Portal extension study indicates the lasting efficacy and safety of ranibizumab dosing via the Port Delivery System.

Late-Breaking CHOICE 2 Data Indicate Alteplase Displayed Improved Stroke Recovery Louie Pasculli

Adding intra-arterial alteplase after successful endovascular thrombectomy significantly improved 90-day functional outcomes in patients with large-vessel acute ischemic stroke, according to late-breaking data from the phase 3 CHOICE2 trial.

Subgroup Signals Emerge for rFVIIa in Acute Intracerebral Hemorrhage in Phase 3 FASTEST Trial Marco Meglio

FASTEST finds rFVIIa curbs ICH bleeding fast but adds clot risk; ultra-early and spot-sign patients show promise as Part 2 continues.

Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis Marco Meglio

Real-world phase 4 data show cladribine keeps relapse rates low and safety steady in relapsing MS patients, including those 65+.

Real-World Data Analysis Highlight Clinical Profiles and Inebilizumab Use Patterns in NMOSD Isabella Ciccone, MPH

A cohort analysis, presented at ACTRIMS 2026, provided insight into the clinical characteristics, disease burden, and treatment sequencing of patients with neuromyelitis optica spectrum disorder treated with inebilizumab.

Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis Noah Stansfield

The analysis included 280 patients from CLARIFY-MS extension and 219 patients from MAGNIFY-MS extension, a total of 499 patients with at least 4 years of follow-up.

Bimekizumab Demonstrates Long Term Efficacy in Hidradenitis Suppurativa

Bimekizumab Demonstrates Long Term Efficacy in Hidradenitis Suppurativa

Todays Updates

PDS Ranibizumab Retains Visual Acuity Gains in nAMD, with John Kitchens, MD John W. Kitchens, MD

The ongoing Archway-Portal extension study indicates the lasting efficacy and safety of ranibizumab dosing via the Port Delivery System.

Late-Breaking CHOICE 2 Data Indicate Alteplase Displayed Improved Stroke Recovery Louie Pasculli

Adding intra-arterial alteplase after successful endovascular thrombectomy significantly improved 90-day functional outcomes in patients with large-vessel acute ischemic stroke, according to late-breaking data from the phase 3 CHOICE2 trial.

Subgroup Signals Emerge for rFVIIa in Acute Intracerebral Hemorrhage in Phase 3 FASTEST Trial Marco Meglio

FASTEST finds rFVIIa curbs ICH bleeding fast but adds clot risk; ultra-early and spot-sign patients show promise as Part 2 continues.

Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis Marco Meglio

Real-world phase 4 data show cladribine keeps relapse rates low and safety steady in relapsing MS patients, including those 65+.

Real-World Data Analysis Highlight Clinical Profiles and Inebilizumab Use Patterns in NMOSD Isabella Ciccone, MPH

A cohort analysis, presented at ACTRIMS 2026, provided insight into the clinical characteristics, disease burden, and treatment sequencing of patients with neuromyelitis optica spectrum disorder treated with inebilizumab.

Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis Noah Stansfield

The analysis included 280 patients from CLARIFY-MS extension and 219 patients from MAGNIFY-MS extension, a total of 499 patients with at least 4 years of follow-up.

Bimekizumab Demonstrates Long Term Efficacy in Hidradenitis Suppurativa

Bimekizumab Demonstrates Long Term Efficacy in Hidradenitis Suppurativa

Latest News

A research team from the INMA Project (Childhood and Environment) has analyzed how pet ownership during early childhood may be related to emotional and behavioral well-being in children. The results suggest that both the ...

Mobile phones and endless screen time are the bane of parents the world over. But while technology is often blamed for poor health in children and teenagers, new University of South Australia research suggests that the same ...

About 4 in 10 of the more than 42 million Americans who get Supplemental Nutrition Assistance Program benefits are children under 18. This food aid helps their families buy groceries and boosts their health in many ways—both ...

Children in many countries are growing up surrounded by violence. It may happen at home, in their neighborhoods, or both. Some children are directly harmed, while others witness violence between caregivers or in their communities. ...

Some babies are born with early blindness due to dense bilateral congenital cataracts, requiring surgery to restore their sight. This period of several months without vision can leave a lasting mark on how the brain processes ...

Providing parenting help through schools led to a significant reduction in anxiety and behavioral problems among children, according to the results of a national study.

News All Time

How to predict developmental differences in kids with heart defects

For decades, it was impossible for clinicians to know which babies with major heart defects might eventually have developmental abnormalities, like ADHD and learning differences. Now, by adapting a simple and safe oxygen ...

The surprising household items putting babies and toddlers at risk

You may think your home is safe once the outlet covers are in, the baby gates are locked and the sharp corners are padded, but some of the biggest dangers to babies and toddlers aren't the ones parents can see.

Children's screen use tied to reduced attention, while reading boosts concentration

Children who use electronic media more frequently tend to show lower levels of attention, while independent reading is associated with better concentration. These are the findings of a survey of more than 1,000 children conducted ...

Food insecurity reported in 13.5% of US children in homes receiving benefits

Overall, 13.5% of U.S. children living in households receiving supplemental nutrition benefit programs have food insecurity (FI), according to a research brief published online Nov. 7 in Pediatrics.

It's OK to walk away: The program saving babies' lives

Researchers invited to evaluate a U.K. program that aims to prevent shaken baby syndrome say the study offers insights that could inform support strategies for Australian parents and caregivers struggling with the stress ...

New screening tool helps identify emotional needs after childhood injuries

Injuries not only cause physical harm to children but can also present psychosocial challenges for pediatric patients and their families.

From baby aisle to lunchbox: The rise of commercial squeeze pouch products in Australian children's diets

New research from Western Sydney University has revealed squeeze pouch products are a popular choice for school lunchboxes, despite their low nutritional value.

Study demonstrates how pediatric integrative medicine can be implemented within a large health system

A new study conducted by University Hospitals Connor Whole Health highlights the impact of pediatric integrative medicine services. This unique self-governing program, operating within UH Rainbow Babies & Children's Hospital, ...

Study reveals stark socioeconomic and ethnic inequalities in neonatal units across England and Wales

A new study using data from all NHS neonatal units in England and Wales has found that mortality rates among babies admitted for specialist care vary significantly depending on socioeconomic background and ethnicity.

Youth with neurodevelopmental conditions experience rare but elevated mortality rates

Young people with neurodevelopmental conditions face substantial and preventable health inequalities, a University of Otago—Ōtākou Whakaihu Waka-led study has found.

Programs aimed at reducing pollution can benefit infant health

Because policies to address pollution are costly to implement and impose social burdens, it is important to understand the full benefits of pollution-reducing programs. An article in Health Economics provides compelling evidence ...

Analysis of 14 million children finds COVID-19 infection poses greater heart complication risk than vaccination

A new study shows children and young people face long-lasting and higher risks of rare heart and inflammatory complications after COVID-19 infection, compared to before or without an infection. Meanwhile, the COVID-19 vaccination ...

Parental emotional support can protect children during war, even when parents suffer from PTSD

Even in the chaos of war, parents can be a shield. A new study published in the International Journal on Child Maltreatment: Research, Policy and Practice finds that parental emotional support helps protect children from ...

Ethical concerns and lack of data leave adolescent psychedelic therapy largely unexplored

There is a growing interest within the medical community in the use of psychedelic therapies to treat conditions ranging from depression and PTSD to anxiety and eating disorders. New research led by McGill University and ...

How teen friendships may predict self harm

Most of us know what it's like to be a teenager at school—and how it feels to fit into (or fall outside of) a school's social hierarchy. This typically includes some version of the popular kids, the loners and the in-betweeners, ...

Shared risk factor may underlie both mental and physical illness in youth

Mental and physical health conditions in children and adolescents are often linked and can be traced back to a shared risk factor, according to new research from Örebro University.

Recommended News For You

Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients

In breast cancer patients with nodes positive, preoperative hydroxyprogesterone may enhance disease-free survival.

Using AI, one can find cancer risk factors.

TRK Inhibitor Active in Treatment-Refractory Glioblastoma

More nonsmokers are getting lung cancer: Oncologist explains why

Immunotherapy in Head and Neck Cancer After Failure of Definitive Therapy.

Is Chemotherapy via Peripheral IV Access More Effective Than Central Lines for Testicular Cancer?

Recommended Articles For You

Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked 

Myeloproliferative Disorders: Causes, Symptoms and Treatment Options  

Liquid Biopsies Unveiling the Future of Precision Cancer Management by 2025 

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study identifies new approach to protect the brain during radiation therapy

2.

Cancer Patients Are Receiving More and More Stupid Immunotherapy.

3.

According to JAMA, women who have false-positive mammogram results are at a higher risk of developing breast cancer over time.

4.

Cancer deaths expected to rise to over 18 million in 2050, nearly 75% more than in 2024

5.

Glofitamab Regimen Improves Survival in DLBCL

1.

Everything You Need to Know About Normal Potassium Levels 

2.

Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact

3.

Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body?

4.

Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals

5.

The Bloodstream Compass: A Comparative Clinical Review of Liquid Biopsy and AI in Predictive Oncology

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part I

2.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

3.

Navigating the Complexities of Ph Negative ALL - Part XVI

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot